Kalipso Chalkidou is the Director of Global Health Policy and a Senior Fellow at the Center for Global Development, based in London, and a Professor of Practice in Global Health at Imperial College London. Her work concentrates on helping governments build technical and institutional capacity for using evidence to inform health policy as they move towards Universal Healthcare Coverage. She is interested in how local information, local expertise and local institutions can drive scientific and legitimate healthcare resource allocation decisions. She has been involved in the Chinese rural health reforms and in national health reform projects in Colombia, Turkey and the Middle East, working with the World Bank, PAHO, DFID and the Inter-American Development Bank as well as national governments.
Between 2007 and 2008, she spent a year at the Johns Hopkins School of Public Health, as a Harkness fellow in Health Policy and Practice, studying how comparative effectiveness research can inform policy and US government drug pricing policies.
Kalipso led the establishment of NICE International which she led for 8 years, and, more recently, of the international Decision Support Initiative (iDSI) which she directs and which is a multi-million multi-country network working towards better health around the world through evidence-informed spending in healthcare in low to middle income countries. IDSI is funded by the Bill and Melinda Gates Foundation, the UK’s Department for International Development and the Rockefeller Foundation and is currently involved in national reform projects in China, India, Vietnam, Ghana, Indonesia and South Africa working together with key organisations such as the Thai Health Intervention and Technology Assessment Program (HITAP), the US Center for Global Development, and PRICELESS, at Wits University in South Africa.
She holds a doctorate on the molecular biology of prostate cancer from the University of Newcastle (UK), an MD (Hons) from the University of Athens and is a visiting Professor at King’s College London and an adjunct professor at Griffith University in Australia. She has held visiting positions at the Johns Hopkins School of Public Health and the London School of Hygiene and Tropical Medicine, sits on several journal editorial boards and has published over 100 peer reviewed papers and book chapters.
et al., 2019, Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy", International Journal of Health Policy and Management, Vol:8, ISSN:2322-5939, Pages:132-135
et al., 2019, On results reporting and evidentiary standards: spotlight on the Global Fund., Lancet
Culyer AJ, Chalkidou K, 2019, Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?, Value in Health, Vol:22, ISSN:1098-3015, Pages:99-103
et al., 2019, How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations, Social Science & Medicine, Vol:220, ISSN:0277-9536, Pages:141-149
et al., 2019, Valuing Protection against Health-Related Financial Risks, Journal of Benefit-cost Analysis, ISSN:2194-5888, Pages:106-131